← SynDRA
SOBUZOXANE
SynDRA canonical compound SYN0024711 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | TOP2A |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
| Indication | peripheral T-cell lymphoma (PTCL) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- PDE3A
- KCNH2
- KDR
- LMNA
- MAOA
- MPHOSPH8
- NFE2L2
- NFKB1
- OPRM1
- PDE4A
- HTR1A
- PGR
- PMP22
- PTGS1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- TDP1
- HTR2B
- HRH3
- ADORA3
- CYP1A2
- ADRA1A
- ADRA2A
- APEX1
- AR
- ARSA
- CBX1
- CHRM1
- CHRM2
- CYP2C19
- GMNN
- CYP2C9
- CYP2D6
- CYP3A4
- DRD1
- DRD3
- EHMT2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
Cross-references
Synonyms
- MST-16
- perazolin
- Sobuzoxano
- MST 16
- Sobuzoxanum
- R1308VH37P
- DTXCID3025203
- RefChem:183492
- MFCD00866498
- Perazolin
- Sobuzoxane (JAN)
- NCGC00015954-02
- SOBUZOXANE [JAN]
- Sobuzoxane [INN:JAN]
- Sobuzoxanum [INN-Latin]
- Sobuzoxano [INN-Spanish]
- C22H34N4O10
- BRN 6031322
- UNII-R1308VH37P
- Perazolin (TN)
- SOBUZOXANE [MI]
- SOBUZOXANE [INN]
- Lopac-S-4692
- SOBUZOXANE [MART.]
- SOBUZOXANE [WHO-DD]
- Lopac0_001094
- SCHEMBL18416
- MLS002153414
- orb3134768
- CHEBI:32136
- OCOKWVBYZHBHLU-UHFFFAOYSA-N
- GLXC-23726
- HMS2230C04
- HMS3263K10
- HMS3369L07
- Tox21_110265
- Tox21_501094
- EX-A10184
Look up SOBUZOXANE in the interactive SynDRA portal →